OUR PRODUCTS

MOBILE APPS

GENERAL INFO

NRSN

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

NeuroSense Therapeutics (NRSN) Earnings Date & Reports

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

NRSN is expected to report earnings to fall 55.05% to -6 cents per share on November 26

NeuroSense Therapeutics NRSN Stock Earnings Reports

Q3'25

Est.

$-0.06

Q2'25

Beat

by $0.09

Q1'25

Beat

by $0.04

Q4'24

Missed

by $0.46

Q3'24

Beat

by $0.03

The last earnings report on August 01 showed earnings per share of -13 cents, beating the estimate of -22 cents. With 169.62K shares outstanding, the current market capitalization sits at 29.28M.

View a ticker or compare two or three

Compare

NRSN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For NRSN
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NRSN showed earnings on August 01, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

11 HaMenofim Street, Building B

Phone

+972 97996183

Employees

Web

https://www.neurosense-tx.com